AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
+30.24%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(+23%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.07% |
| 2 | Technology | 2.38% |
| 3 | Communication Services | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intellia Therapeutics
NTLA
$1.22B
| $27.6M | 25.92% |
1,615,321
| – | – |
|
|
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $22.2M | 20.82% |
4,645,453
| – | – |
|
3
Synlogic
SYBX
$17M
| $20.1M | 18.91% |
2,651,963
| – | – |
|
4
Spero Therapeutics
SPRO
$116M
| $17.6M | 16.57% |
1,376,968
| – | – |
|
5
Cogent Biosciences
COGT
$1.69B
| $14.8M | 13.86% |
3,361,535
| – | – |
|
|
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $2.53M | 2.38% |
181,273
| – | – |
|
7
Snap
SNAP
$12.1B
| $1.66M | 1.55% |
150,160
| – | – |
|